
Molecular detection of Coxiella burnetii infection in patients with a negative infective endocarditis culture following cardiovascular surgery
- Authors:
- Published online on: November 1, 2023 https://doi.org/10.3892/wasj.2023.210
- Article Number: 33
-
Copyright : © Duong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Abstract
Introduction
Coxiella burnetii (C. burnetii) is an obligate intracellular bacterium and its common intermediate hosts are cattle, sheep and goats. Pathogens transmitted by the inhalation of biological product particles can travel a great distance (several kilometers), in many cases, without the patient being in direct contact with the pathogen (1). The most common infection caused by C. burnetii is acute Q fever, characterized by pneumonia and hepatitis. In some countries, outbreaks of >3,000 simultaneous Q fever cases have been recorded, forming an outbreak with a mortality rate of up to 2% (France in 2007 and The Netherlands in 2010) (2). El-Mahallawy et al (3) evaluated the prevalence of C. burnetii infection in a group of 180 healthy individuals in China and found the prevalence of C. burnetii to be 25%. The results of their study revealed that C. burnetii infection was a relatively common disease in that country, in both urban and rural areas, similar to other European countries (3). Chronic Q fever due to C. burnetii infection usually accounts for 1-5% of C. buretii infections (4). C. burnetii has a long incubation period; the time recorded between first exposure and clinical manifestations can vary from 1 year to >1 decade (5). Common risk factors in patients with C. burnetii endocarditis are the male sex (75%), an age between 40 and 70 years, valvular disease (91%); particularly the presence of prosthetic valves (30-55%) and immunocompromised patients (32%) (5).
The manifestations of infective endocarditis due to C. burnetii are non-specific and this is the cause of the untimely diagnosis of this condition. Almost 50% of patients with C. burnetii endocarditis have symptoms of acute heart failure and the majority of patients have a fever (70%), and suffer from weight loss, fatigue and anorexia (50%). Other manifestations include a rash on the extremities and mucous membranes, changes in the levels of hematological parameters, splenomegaly and renal injury caused by immune disorders (2). It has been demonstrated that some cases of endocarditis have negative blood cultures, as demonstrated in the study by Houpikian and Raoult in 2005(6). Negative blood cultures can be caused by a variety of factors, including the method used to obtain the specimen, the culture medium used and previous antibiotic therapy (7). The study performed in France by Fournier et al (8) developed a multimodal strategy for the diagnosis of negative endocarditis when blood cultures were negative. The methods used in their study included classical serology and PCR analysis of the blood samples; PCR revealed an increase in diagnostic efficiency of up to 24.3%, and the authors of that study thus suggested that these tests should be used as a standard in studies on C. Burnetii (8).
At the Cardiovascular Surgery Unit, Bach Mai Hospital (Hanoi, Vietman), the authors also found that among the patients undergoing cardiovascular surgery due to endocarditis, there were some patients with post-operative infectious complications, including some patients who had a negative blood culture. Given the complications of endocarditis caused by C. burnetii that have been previously reported, the present study was performed in an aim to recommend further tests and treatment regimens for patients with endocarditis (7).
Patients and methods
Patients
A total of 312 patients with endocarditis operated at the Cardiovascular Surgery Unit of Bach Mai Hospital, from January, 2022 to February, 2023, aged 17 to 74 years, male:female ratio was 1.6:1 (193 male patients), were diagnosed with endocarditis and required surgery. The patients were subjected to a full range of examinations, such as hematological analysis, coagulation analysis, microbiology tests, including hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV, as well as medical history, if necessary. Following surgery, the heart valve tissue of the patients was cultured. In the case that the results of the culture are negative, the DNA was separated from the blood, and PCR analysis for C. burnetii bacteria was performed using specific primer pairs. All the aforementioned procedures were approved by the Medical Ethics Committee of Bach Mai Hospital and following the written consent of the patients or their parents (for 2 patients who were underage).
PCR technique and PCR cycle
Blood DNA was separated using the Qiagen kit (Qiagen, Inc.). The primer sequences specific to C. burnetii used were as follows: Forward, 5'-ACGGGTGAGTAATGCGTAGG-3' and reverse, 5'-CAGTATCGGGTGCAATTCCCAG-3.
The PCR assays were performed using an Eppendorf model 5382 Thermo Mixer C thermal cycler (BCE Vietnam) according to the following procedure: An initial denaturation at 95˚C for 15 min; 45 cycles at 95˚C for 30 sec, 57˚C (for the first primer pair) or 62˚C (for the second primer pair) for 30 sec and 72˚C for 30 sec; and a final elongation step at 72˚C for 7 min. The amplification of 5 µl DNA was performed in a total volume of 25 µl containing 10X PCR buffer (Qiagen, Inc.), 2.5 mM MgCl2, 0.25 mM deoxynucleotide triphosphate, 25 pmol of each primer, and 1 unit of Taq DNA polymerase (Qiagen, Inc.). Agarose gel electrophoresis (2%) in the presence of ethidium bromide was used to separate the PCR products.
Hematoxylin and eosin (H&E) staining
For H&E staining, a bone marrow biopsy was performed at the posterior superior iliac spine. The sample was 10-20 mm in length and was fixed with 5% formaldehyde, and subjected to decalcification and decontamination with alcohol, xylene and molded with paraffin melting at 61˚C. Staining was performed using H&E (Diapath S.P.A.) at room temperature. The thickness of sections was 0.2 mm. The sample was examined using a light microscope (Olympus Corporation) with a 40X objective.
Patient treatment
Patients with positive results for C. burnetii infection were treated with a regimen of doxycilin 600 mg/day for 7-10 days in combination with other antibiotics, such as imipenem and cilastatin at a dose of 1-2 g/day and their clinical progress was monitored, with periodical follow-up following hospital discharge.
Results
Out of the total of 312 patients with infective endocarditis who underwent surgery, 52 patients had negative blood and cardiac tissue cultures following surgery. Using the PCR technique with a 16s RNA primer pair of C. burnetii to analyze the 52 negative bacterial culture samples, 13 samples tested positive for C. burnetii at 460 bp; these patients had both mitral and tricuspid valve lesions, abscesses and circuit occlusion (Table I).
Patients with positive results for C. burnetii were tested for other viruses, including HIV, HCV, HBV, Epstein-Barr virus, vytomegalovirus and influenza, all of which yielded negative results. Following surgery, the group of patients positive for C. burnetii also had more severe clinical manifestations than the group of patients with negative results. The clinical lesions of the patients with C. burnetii infection following surgery encountered included a high fever >38˚C, pneumonia, weight loss, liver failure, kidney failure, including 2 patients with severe multi-organ failure. All patients with C. burnetii infection had a high fever >38˚C, lasting for >14 days; the longest fever duration observed was almost 40 days. Pneumonia and liver damage were recorded at a high rate in this group of patients at a rate of 84.6 and 76.9%, respectively (Table II).
![]() | Table IIClinical manifestations following surgery in patients positive for Coxiella burnetii infection. |
The mean duration of hospitalization in the C. burnetii-positive group was 41.5 days, which was a markedly longer post-operative hospitalization period than the patients with negative C. burnetii results (Table III).
All patients infected with C. burnetii in the present study had anemia and thrombocytopenia; 3/13 patients had leukopenia. The average hemoglobin level of the patients was 93.6 g/l (range, 74-110 g/l). 9 patients had mild anemia, and 1 patient had moderate anemia. At its lowest, the level of hemoglobin was 74 g/l. A total of 3 patients had moderate or slightly elevated white blood cell counts, with 3/13 cases having decreased white blood cell counts, with a decreased neutrophil ratio (average, <35%). The average platelet count was 85.9x109/l (Table IV).
![]() | Table IVChanges in the levels of hematological parameters in patients positive for Coxiella burnetii infection. |
In particular, there was 1 case (patient no. 6; Table IV) with pancytopenia and neutrophils were reduced by 0.4x109/l. This patient subsequently had a bone marrow biopsy and was found to have multiple fibrin-ring granulomas (Fig. 1).
Among these cases, there were patients with both mitral and tricuspid valve lesions, or both mitral valve lesions and occlusion (Fig. 2). This patient was admitted to the hospital with breathing difficulties, which gradually increased for ~1 year. This patient was a male at 26 years of age. The tests to identify the cause of endocarditis prior to surgery were all negative. This is also one of the 2 cases of post-operative endocarditis with multi-organ failure.
Another patient succumbed 6 months following mitral valve surgery due to continued damage to the tricuspid valve, sepsis and multi-organ failure, who also tested positive for C. burnetii.
Discussion
There were 52/312 patients with negative results for bacterial culture following cardiovascular surgery, determined using an automatic identification system. When analyzing these 52 samples, it was found that 13/52 cases had the presence of C. burnetii bacteria in the analyzed blood samples (Table I). Blood cultures or tissue fragments following surgery are often negative, which has been explained by a number of factors that limit blood culture results, including pre-operative antibiotic use, the specimen collection method and culture medium used, as well as previous antibiotic therapy (7). In the study by Fournier et al (8), it was found that the PCR method increased 24.3% sensitivity to detect the presence of C. burnetii in the blood of patients. C. burnetii is also the most commonly reported organism in cases of culture-negative endocarditis. When studying 283 cases of endocarditis with negative blood cultures, Fournier et al (8) found that C. burnetii was present in 27 cases (9.5%), exhibiting a higher proportion than other cases. Other pathogens included Bartonella spp., Brucella spp., Tropheryma whipplei, Mycoplasma spp. and Legionella spp., accounting for up to 5% of all diagnoses of infective endocarditis (8). According to another study by Houpikian and Raoult (6) in a large study on culture-negative endocarditis from 1983-2001 in France, it was found that C. burnetii accounted for 48% of all cases diagnosed with infective endocarditis with negative blood cultures. In the present study, 13/52 cases of endocarditis with negative blood cultures were detected with C. burnetii infection, accounting for 25%, similar to the results of the study by Fournier et al (8), but markedly lower than the research results of Houpikian and Raoult (6). A few case reports of post-operative complications due to C. burnetii have been reported by cardiovascular surgeons, such as that of Deyell et al in 2003(9). In the present study, there was 1 patient who, after the first surgery to repair the mitral valve lesions and remove the wart, had to have a second surgery to correct the tricuspid valve; this patient then exhibited signs of a continuous high fever, multi-organ failure and a severe clinical course.
In a previous study, patients with valvular heart disease and Q fever due to acute C. burnetii infection were shown to have a 38.7% chance of developing endocarditis (10). Patient exposure to animals has been reported in 70% of cases, with patients not even realizing they have been infected (10). Manifestations of C. burnetii causing infective endocarditis are non-specific and this is the cause of the untimely diagnosis of this condition. Almost 50% of patients have symptoms of acute heart failure and the majority of patients suffer from fever (70%), weight loss, fatigue and anorexia (50%). Manifestations include a rash on the extremities and mucous membranes, changes in the levels of hematological parameters, splenomegaly and kidney injury caused by immune disorders (11), all of which can lead the patients' conditions being confused with other clinical conditions.
Molecular techniques for diagnosing endocarditis from surgical tissues have been available for >20 years and have become increasingly critical in the diagnosis of endocarditis (12). These techniques detect the causative organism in the majority of cases of blood culture-negative endocarditis and may represent a major step forward in the management of endocarditis cases in which antibiotics are used before culture, in patients with inconclusive serological results, in cases where culture and serology are negative or, where serological testing is not available (13,14). Furthermore, molecular sequencing improves the understanding of the true etiology of endocarditis in different countries and represents a major step forward in the diagnostic and management of this disease (14,15).
Asian countries near Vietnam, such as China and Korea have all recorded the presence of C. burnetii; the study by Huang et al (16) recorded an outbreak of a C. burnetii infection in a city in China (16). The study by Bae et al (17) conducted in Korea, recorded 8/40 cases of C. burnetii negative blood culture endocarditis using PCR analysis (17).
The aforementioned studies exhibit a common factor, namely that the detection of C. burnetii endocarditis is difficult using conventional bacterial culture alone, and the PCR technique is considered a superior technique in determining the presence of bacteria C. burnetii (13,14). In the present study, the patients in the C. burnetiii-positive group identified using the PCR method exhibited worse clinical signs than the negative group, such as a persistent high fever following surgery, pneumonia, elevated levels of liver enzymes (aspartate aminotransferase/alanine aminotransferase) and weight loss, leading to a longer hospitalization period (Table II). Deyell et al (9) reported a case with complications requiring re-valve surgery due to latent damage by C. burnetii infection. In the present study, the majority of the patients had no/unrecorded cardiac damage that warranted re-surgery. However, there was 1 case of endocarditis with damage to both the mitral and tricuspid valves (Fig. 2); following surgery, the patient exhibited a severe clinical presentation, multi-organ failure, and a 16 kg weight loss within 20 days; this patient was found to be positive for C. burnetii using PCR, and the patient was actively treated immediately after the infection was detected and was discharged after 62 days of treatment. This was the case with the longest hospitalization period. Multinucleated giant cells without a fibrin ring have also been described in the study by Jang et al (18) on C. burnetii infection in patients with endocarditis who had undergone surgery. Another patient in the present study died 6 months following mitral valve surgery due to continued damage to the tricuspid valve, sepsis and multi-organ failure, who also tested positive for C. burnetii infection. The delayed detection of the presence of C. burnetii may reduce the treatment efficacy. In the present study, patients positive for C. burnetii infection had a longer hospitalization period than the negative group (Table III). This also becomes a burden for patients and their families, doctors and as hospitals. To the best of our knowledge, the present study is the first in Vietnam using molecular biology to detect C. burnetii in the blood of patients with negative culture results following surgery for endocarditis. Better better research results can be achieved using 16S RNA primers analyzed on surgically operated valvular tissue.
In conclusion, edocarditis caused by C. burnetii infection is difficult to detect, and can cause a number of cardiovascular complications, limiting the effectiveness of cardiovascular surgery. The sources of C. burnetii infection are diverse, and are derived from numerous hosts; in the event that this type of infection is suspected, it is necessary to send samples to reputable laboratories for identification, in order to provide an effective intervention and treatment regimen for affected patients.
Acknowledgements
Not applicable.
Funding
Funding: No funding was received.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Authors' contributions
HDD conceived the study and was the main surgeon for the patients. ATVD and TMV obtained the patient samples and wrote the manuscript. HTVB and ATVD performed the analysis of the samples and PCR analysis. All authors have edited and agree to the reported content of the manuscript and all authors have read and approved the final manuscript. HDD and ATVD confirm the authenticity of all the raw data.
Ethics approval and consent to participate
The study received ethical approval from the Medical Ethics Committee of Bach Mai Hospital (Hanoi, Vietnam) and informed consent was obtained from all patients participating in the study. For 2 patients who were underage, the parents provided the consent.
Patient consent for publication
The patient whose Doppler echocardiography image is presented in Fig. 2 provide written informed consent for the publication of his data and the related images.
Competing interests
The authors declare that they have no competing interests.
References
Maurin M and Raoult D: Q fever. Clin Microbiol Rev. 12:518–553. 1999.PubMed/NCBI View Article : Google Scholar | |
Hanssen DAT, Morroy G, de Lange MMA, Wielders CCH, van der Hoek W, Dijkstra F and Schneeberger PM: Notification data and criteria during a large Q-fever epidemic reassessed. Epidemiol Infect. 147(e191)2019.PubMed/NCBI View Article : Google Scholar | |
El-Mahallawy HS, Kelly P, Zhang J, Yang Y, Wei L, Tian L, Fan W, Zhang Z and Wang C: Serological and molecular evidence of Coxiella burnetii in samples from humans and animals in China. Ann Agric Environ Med. 23:87–91. 2016.PubMed/NCBI View Article : Google Scholar | |
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, et al: 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 36:3075–3128. 2015.PubMed/NCBI View Article : Google Scholar | |
Wilson HG, Neilson GH, Galea EG, Stafford G and O'brien MF: Q fever endocarditis in Queensland. Circulation. 53:680–684. 1976.PubMed/NCBI View Article : Google Scholar | |
Houpikian P and Raoult D: Blood culture-negative endocarditis in a reference center: Etiologic diagnosis of 348 cases. Medicine (Baltimore). 84:162–173. 2005.PubMed/NCBI View Article : Google Scholar | |
Brouqui P and Raoult D: New insight into the diagnosis of fastidious bacterial endocarditis. FEMS Immunol Med Microbiol. 47:1–13. 2006.PubMed/NCBI View Article : Google Scholar | |
Fournier PE, Gouriet F, Casalta JP, Lepidi H, Chaudet H, Thuny F, Collart F, Habib G and Raoult D: Blood culture-negative endocarditis: Improving the diagnostic yield using new diagnostic tools. Medicine (Baltimore). 96(e8392)2017.PubMed/NCBI View Article : Google Scholar | |
Deyell MW, Chiu B, Ross DB and Alvarez N: Q fever endocarditis: A case report and review of the literature. Can J Cardiol. 22:781–785. 2006.PubMed/NCBI View Article : Google Scholar | |
Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T and Raoult D: Risks factors and prevention of Q fever endocarditis. Clin Infect Dis. 33:312–316. 2001.PubMed/NCBI View Article : Google Scholar | |
Houpikian P, Habib G, Mesana T and Raoult D: Changing clinical presentation of Q fever endocarditis. Clin Infect Dis. 34:E28–E31. 2002.PubMed/NCBI View Article : Google Scholar | |
Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Célard M, Mainardi JL, Caus T, et al: Comprehensive diagnostic strategy for blood culture-negative endocarditis: A prospective study of 819 new cases. Clin Infect Dis. 51:131–140. 2010.PubMed/NCBI View Article : Google Scholar | |
Goldenberger D, Künzli A, Vogt P, Zbinden R and Altwegg M: Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol. 35:2733–2739. 1997.PubMed/NCBI View Article : Google Scholar | |
Moter A, Musci M and Schmiedel D: Molecular methods for diagnosis of infective endocarditis. Curr Infect Dis Rep. 12:244–252. 2010.PubMed/NCBI View Article : Google Scholar | |
Calabrese F, Carturan E and Thiene G: Cardiac infections: Focus on molecular diagnosis. Cardiovasc Pathol. 19:171–182. 2010.PubMed/NCBI View Article : Google Scholar | |
Huang M, Ma J, Jiao J, Li C, Chen L, Zhu Z, Ruan F, Xing L, Zheng X, Fu M, et al: The epidemic of Q fever in 2018 to 2019 in Zhuhai city of China determined by metagenomic next-generation sequencing. PLoS Negl Trop Dis. 15(e0009520)2021.PubMed/NCBI View Article : Google Scholar | |
Bae M, Lee HJ, Park JH, Bae S, Jung J, Kim MJ, Lee SO, Choi SH, Kim YS, Shin Y and Kim SH: Molecular diagnosis of Coxiella burnetii in culture negative endocarditis and vascular infection in South Korea. Ann Med. 53:2256–2265. 2021.PubMed/NCBI View Article : Google Scholar | |
Jang YR, Song JS, Jin CE, Ryu BH, Park SY, Lee SO, Choi SH, Soo Kim Y, Woo JH, Song JK, et al: Molecular detection of Coxiella burnetii in heart valve tissue from patients with culture-negative infective endocarditis. Medicine (Baltimore). 97(e11881)2018.PubMed/NCBI View Article : Google Scholar |